News & Updates

Alirocumab administered every 2 or 4 weeks (Q2W or Q4W) significantly reduced low-density lipoprotein-cholesterol (LDL-C) levels in paediatric patients with heterozygous familial hypercholesterolaemia (HeFH), according to a study presented at ESC 2023.

Brain disorders – comprising mental illness, neurologic conditions, and stroke – account for over 15 percent of global health loss (how much healthy life is lost due to early death, illness, or ability) in the Global Burden of Disease (GBD) study presented at EAN 2023.

Older adults who engage in activities during their leisure time for pleasure appear to be less depressed and are happier and more satisfied with their life in general, as shown in a study.

A study presented at ERS 2023 revealed a potential causal relationship between smoking and length of telomeres, which are the DNA-protein complexes protecting the ends of chromosomes.

The International Society of Hypertension (ISH) has recently put out a position paper that addresses lifestyle management of hypertension. The paper is endorsed by the World Hypertension League and European Society of Hypertension. [DOI:10.1097/HJH.0000000000003563]